安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Home - CHARM Therapeutics
That’s the promise of menin inhibitors CHARM is taking this one step further with its next generation best-in-class menin inhibitor designed to address resistance observed with first generation menin approaches and deliver a durable treatment to patients
- News - CHARM Therapeutics
Keep up to date with all of the latest company news, press releases and updates News_ Transforming outcomes for patients living with AML
- About - CHARM Therapeutics
About_ Founded by leaders with a track record in next-wave AI and drug discovery, the CHARM team is now focused on demonstrating the potential for its next
- Contact - CHARM Therapeutics
Contact_ CHARM Therapeutics Ltd 7 Pancras Sq London N1C 4AG info@charmtx com View Map_ B900 Babraham Research Campus Cambridge CB22 3AT info@charmtx com V
- Our Approach - CHARM Therapeutics
Our Approach_ Pioneering a new generation best-in-class menin inhibitor for acute myeloid leukemia, a disease of high unmet need Discover Our Approach to T
- CHARM Therapeutics raises $80 million in Series B financing to advance . . .
LONDON – 2 September 2025 — CHARM Therapeutics (“CHARM”, “The Company”), announces closing of an oversubscribed Series B funding round, raising $80 million to advance its next generation menin inhibitor into clinical development The financing was supported by a strong syndicate of both existing and new global investors, reflecting confidence in the Company’s breakthrough
- CHARM Therapeutics advances CHM-029, a next-generation menin inhibitor . . .
About CHARM Therapeutics Founded by Laksh Aithani and David Baker, CHARM Therapeutics is a biotechnology company pioneering the next generation of precision oncology treatments through its proprietary AI-driven drug discovery platform CHARM’s lead program is a next generation menin inhibitor for the treatment of acute myeloid leukemia (AML)
- Laksh Aithani - CHARM Therapeutics
Prior to founding CHARM, he was a core contributor at Exscientia (NASDAQ:EXAI), a leading AI drug discovery company, where he worked on their machine learning platform Laksh started his entrepreneurship journey as an undergraduate, co-founding Genei, an AI company, which has since gone through Y-Combinator and raised a seed round from Silicon Valley investors Laksh gained a degree in Natural
|
|
|